Skip to main content

Table 3 Regulators associated with M6A methylation in autoimmune diseases

From: M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics

Disease

The m6A regulators

Type

Sample source

Expression change

Regulatory roles

Reference

RA

IGFBP2

Reader

FLS

Up-regulation

Regulates the neuropeptides GHR and NPR2 to influence the interaction between FLS.

[37]

RA

IGF2BP3

Reader

Synovial tissues

Up-regulation

Regulates the G2/M transition and affects the polarization of M1 macrophages.

[38]

RA

SMOC2

-

Synovial tissues

Up-regulation

Controls MYO1C expression through ALKBH5-mediated m6A modification.

[40]

RA

METTL3

Writer

PBMC

Up-regulation

Attenuated LPS-induced inflammatory response in macrophages via the NF-κB signaling pathway.

[41]

RA

METTL3

Writer

FLS

Up-regulation

Activates the NF-κB signaling pathway.

[43]

RA

WTAP

Writer

MH7A cells

Up-regulation

Combines with METTL3 to form the MettL3–MettL14–Wtap complex.

[52]

RA

RIPK2

-

MH7A cells

Up-regulation

Mediates LPS-induced p38 and IKB-α signaling.

[52]

RA

JAK3

-

MH7A cells

Up-regulation

Mediates and participates in the formation of cytokines.

[52]

RA

TNFRSF10A

-

MH7A cells

Down-regulation

Activates the NF-κB pathway and promotes cell proliferation and migration.

[52]

RA

YTHDF2

Reader

PBMC

Down-regulation

Affects the production of autoantibodies.

[53]

RA

FTO

Eraser

Peripheral blood

Down-regulation

Mediates methylation reversal.

[53]

RA

ALKBH

Eraser

Peripheral blood

Down-regulation

Mediates methylation reversal.

[53]

SLE

ALKBH5

Eraser

Peripheral blood

Down-regulation

Affects anti-DSDNA levels

[63]

SLE

MTEEL14

Writer

Peripheral blood

Down-regulation

Perturbs the m6A threshold, leading to uncontrolled expression/activity of the virulence gene.

[64]

SLE

YTHDF2

Reader

Peripheral blood

Down-regulation

Perturbs the m6A threshold, leading to uncontrolled expression/activity of the virulence gene.

[64]

pSS

METTL3

FTO

YTHDF1

YTHDF2

Writer

Eraser

Reader

Reader

PBMC

Up-regulation

Targets ISG15, stimulates ISG15 expression, and activates the type I IFN signaling pathway.

[72]

Graves’Disease

METTL3

Writer

CD4T cells

Down-regulation

Induces SOCS mRNA m6A modification.

[79]

MS

ALKBH5

Eraser

T cells

Up-regulation

Controls CD4 T cell pathogenicity.

[89]

Uveitis

FTO

Eraser

EAU mouse RPE cells

Down-regulation

Regulates the m6A level of ATF4 to affect the translation of ATF4 and the expression of inflammatory factors.

[92]

Autoimmune hepatitis

YTHDF2

Reader

liver

Up-regulation

Low expression of YTHDF2 can enhance the amplification, chemotaxis, and inhibition of MDSC.

[96]